{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:29:32Z","timestamp":1776274172607,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the phase III RTS,S \/AS01 trial, significant heterogeneity in efficacy of the vaccine across study sites was seen. Question on whether variations in socio - economic status (SES) of participant contributed to the heterogeinity of the vaccine efficacy (VE) remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from the Phase III RTS,S \/AS01 trial in children aged 5\u201317\u2009months in Kintampo were re-analysed. SES of each child was derived from the Kintampo Health and Demographic Surveillance System, using principal component analysis of household assets. Extended Cox regression was used to estimate the interaction between RTS,S\/AS01 VE and household SES.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Protective efficacy of the RTS,S\/AS0 vaccine significantly varied by participant\u2019s household SES, thus increase in household SES was associated with an increase in protective efficacy (<jats:italic>P<\/jats:italic>-value\u2009=\u20090.0041). Effect modification persisted after adjusting for age at first vaccination, gender, distance from community to the health facility, child\u2019s haemoglobin level, household size, place of residence and mothers\u2019 educational level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Household SES may be a proxy for malaria transmission intensity. The study showed a significant modification of the RTS,S\/AS01 malaria vaccine efficacy by the different levels of child\u2019s household socio - economic status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Efficacy of GSK Biologicals\u2019 candidate malaria vaccine (25049) against malaria disease in infants and children in Africa. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00866619\">NCT00866619<\/jats:ext-link> prospectively registered on 20 March 2009.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-10294-x","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T17:08:15Z","timestamp":1611853695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential effect modification of RTS,S\/AS01 malaria vaccine efficacy by household socio-economic status"],"prefix":"10.1186","volume":"21","author":[{"given":"Stephaney","family":"Gyaase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisha","family":"Adeniji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owusu","family":"Boahen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"10294_CR1","volume-title":"2017 Annual Report","author":"National Malaria Control Programme","year":"2017","unstructured":"National Malaria Control Programme. 2017 Annual Report. Accra: Ghana Health Service; 2017."},{"key":"10294_CR2","doi-asserted-by":"publisher","DOI":"10.30875\/7e6f8c91-en","volume-title":"World Malaria Report 2019","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. World Malaria Report 2019. 2019."},{"issue":"12","key":"10294_CR3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","volume":"368","author":"A Olotu","year":"2013","unstructured":"Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, et al. Four-year efficacy of RTS, S\/AS01E and its interaction with malaria exposure. N Engl J Med. 2013;368(12):1111\u201320.","journal-title":"N Engl J Med"},{"issue":"7","key":"10294_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001685","volume":"11","author":"RTS SCTP","year":"2014","unstructured":"RTS SCTP. Efficacy and safety of the RTS, S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11(7):e1001685.","journal-title":"PLoS Med"},{"issue":"10","key":"10294_CR5","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1080\/21645515.2016.1189038","volume":"12","author":"V Gosselin","year":"2016","unstructured":"Gosselin V, G\u00e9n\u00e9reux M, Gagneur A, Petit G. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Hum Vaccin Immunother. 2016;12(10):2572\u20139.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10294_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041720","volume":"7","author":"BA Lopman","year":"2012","unstructured":"Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One. 2012;7(8):e41720.","journal-title":"PLoS One"},{"issue":"1","key":"10294_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1186\/s12889-016-3673-x","volume":"16","author":"R Hammer","year":"2016","unstructured":"Hammer R, Capili C, Wi C-I, Ryu E, Rand-Weaver J, Juhn YJ. A new socioeconomic status measure for vaccine research in children using individual housing data: a population-based case-control study. BMC Public Health. 2016;16(1):1000.","journal-title":"BMC Public Health"},{"issue":"10","key":"10294_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007302","volume":"4","author":"S Owusu-Agyei","year":"2009","unstructured":"Owusu-Agyei S, Ansong D, Asante K, Owusu SK, Owusu R, Brobby NAW, et al. Randomized controlled trial of RTS, S\/AS02D and RTS, S\/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One. 2009;4(10):e7302.","journal-title":"PLoS One"},{"issue":"9","key":"10294_CR9","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/infdis\/jit366","volume":"208","author":"KP Asante","year":"2013","unstructured":"Asante KP, Owusu-Agyei S, Cairns M, Dodoo D, Boamah EA, Gyasi R, et al. Placental malaria and the risk of malaria in infants in a high malaria transmission area in Ghana: a prospective cohort study. J Infect Dis. 2013;208(9):1504\u201313.","journal-title":"J Infect Dis"},{"issue":"9988","key":"10294_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"S Rts","year":"2015","unstructured":"Rts S. Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31\u201345.","journal-title":"Lancet"},{"issue":"1","key":"10294_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1475-2875-10-224","volume":"10","author":"A Leach","year":"2011","unstructured":"Leach A, Vekemans J, Lievens M, Ofori-Anyinam O, Cahill C, Owusu-Agyei S, et al. Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S\/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J. 2011;10(1):224.","journal-title":"Malar J"},{"issue":"6","key":"10294_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/heapol\/czl029","volume":"21","author":"S Vyas","year":"2006","unstructured":"Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21(6):459\u201368.","journal-title":"Health Policy Plan"},{"issue":"4","key":"10294_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","volume":"10","author":"PK Andersen","year":"1982","unstructured":"Andersen PK, Gill RD. Cox\u2019s regression model for counting processes: a large sample study. Ann Stat. 1982;10(4):1100\u201320.","journal-title":"Ann Stat."},{"issue":"3","key":"10294_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/aje\/kwq099","volume":"172","author":"Y Xu","year":"2010","unstructured":"Xu Y, Cheung Y, Lam K, Tan S, Milligan P. A simple approach to the estimation of incidence rate difference. Am J Epidemiol. 2010;172(3):334\u201343.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10294_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/aje\/kwm147","volume":"166","author":"C Kelly","year":"2007","unstructured":"Kelly C, Arnold R, Galloway Y, O'Hallahan J. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. Am J Epidemiol. 2007;166(7):817\u201323.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10294_CR16","first-page":"132","volume":"4","author":"E Bbaale","year":"2016","unstructured":"Bbaale E, Okumu IM. Socio-economic status and malaria prevalence among infants: the case of Uganda. Afr J Econ Rev. 2016;4(1):132\u201342.","journal-title":"Afr J Econ Rev"},{"issue":"2","key":"10294_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002234","volume":"14","author":"LS Tusting","year":"2017","unstructured":"Tusting LS, Bottomley C, Gibson H, Kleinschmidt I, Tatem AJ, Lindsay SW, et al. Housing improvements and malaria risk in sub-Saharan Africa: a multi-country analysis of survey data. PLoS Med. 2017;14(2):1\u201315.","journal-title":"PLoS Med."},{"issue":"1","key":"10294_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12936-015-0724-1","volume":"14","author":"LS Tusting","year":"2015","unstructured":"Tusting LS, Ippolito MM, Willey BA, Kleinschmidt I, Dorsey G, Gosling RD, et al. The evidence for improving housing to reduce malaria: a systematic review and meta-analysis. Malar J. 2015;14(1):209.","journal-title":"Malar J"},{"issue":"1","key":"10294_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1475-2875-9-201","volume":"9","author":"AC Krefis","year":"2010","unstructured":"Krefis AC, Schwarz NG, Nkrumah B, Acquah S, Loag W, Sarpong N, et al. Principal component analysis of socioeconomic factors and their association with malaria in children from the Ashanti region, Ghana. Malar J. 2010;9(1):201.","journal-title":"Malar J"},{"issue":"11","key":"10294_CR20","doi-asserted-by":"publisher","first-page":"2154S","DOI":"10.3945\/jn.109.105312","volume":"139","author":"M Savy","year":"2009","unstructured":"Savy M, Edmond K, Fine PE, Hall A, Hennig BJ, Moore SE, et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr. 2009;139(11):2154S\u2013218S.","journal-title":"J Nutr"},{"issue":"2","key":"10294_CR21","first-page":"145","volume":"17","author":"DE Velasquez","year":"2018","unstructured":"Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines. 2018;17(2):145\u201361.","journal-title":"Expert Rev Vaccines"},{"issue":"14","key":"10294_CR22","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"C Drakeley","year":"2005","unstructured":"Drakeley C, Corran P, Coleman P, Tongren J, McDonald S, Carneiro I, et al. Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci. 2005;102(14):5108\u201313.","journal-title":"Proc Natl Acad Sci"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-021-10294-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T17:09:32Z","timestamp":1611853772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-10294-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10294"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-10294-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Ethics Committees of the Ghana Health Service, Kintampo Health Research Centre, and the London School of Hygiene and Tropical Medicine, for the conduct of the clinical trial. Written Informed Consent was obtained from mothers or caregivers of all the participants involved in the clinical trial. These study findings come from secondary data obtained from the clinical trial. Approval was obtained from the clinical trial team and the Kintampo Health Research centre.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}